Clinical Study
De Novo Donor-Specific HLA Antibody Development and Peripheral Cells in Kidney Transplant Recipients: A Place for Interaction?
Table 2
Acute rejection episodes.
| | DSA− N = 36 | DSA+ N = 17 |
| Number (%) of patients with acute rejection episodes | 2 (5.6) | 6 (35.3)* | Number of acute rejection episodes | 3 | 9 | Banff 97 grade and the 03 update working classification | | | Acute/active cellular rejection | | | Mild acute (IA) | 1 | 1 | Mild acute (IB) | 0 | 3 | Moderate acute (IIA) | 1 | 1 | Moderate acute (IIB) | 0 | 0 | Severe acute (III) | 0 | 1 | Antibody-mediated rejection | | | I | 0 | 0 | II | 1 | 2 | III | 0 | 1 |
|
|
(Fisher exact test).
|